Deadline: 7 October 2016
The Target Research Platform (TRP), in partnership with Bill & Melinda Gates Foundation’s Grand Challenges program, invites applications for Global Health Innovative Technology Fund (GHIT Fund) grants, focused on promoting the discovery and development of new health technologies, including drugs, vaccines, and diagnostics for infectious diseases prevalent in developing countries.
The GHIT Fund endeavors to facilitate collaboration and funding of global health technology R&D originating from Japan, to build momentum, and to demonstrate action and results.
The Target Research Platform in Partnership with Grand Challenges (TRP) is one of three platforms within the GHIT Fund’s Discovery Investment focus area and is the GHIT Fund’s newest platform. The Grand Challenges platform is intended to support a crucial, earlier phase of R&D—discovery of new approaches, concepts, constructs and solutions to fight neglected infectious disease.
Funding and Duration
A maximum budget per proposal is set at ¥100,000,000. The duration of the project shall not exceed two years.
Eligibility Criteria
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
How to Apply
Applications must be submitted online via given website.
Eligible Country: Japan
For more information, please visit GHIT Fund.